Clicky

Agenus Inc.(AGEN) News

Date Title
Sep 3 Agenus to Participate in September Investor Conferences
Jul 26 The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical
Jul 26 Agenus to Provide Second Quarter 2024 Financial Report and Corporate Update
Jul 12 IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?
Jun 28 Sector Update: Health Care Stocks Edge Higher in Afternoon Trading
Jun 28 Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference
Jun 27 Cancer Therapy Evaluation Program Announces Availability of Botensilimab for Clinical Studies
Jun 13 Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50
May 8 Agenus Inc. (NASDAQ:AGEN) Q1 2024 Earnings Call Transcript
May 8 Agenus First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 8 Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and ...
May 7 Agenus (AGEN) Q1 2024 Earnings Call Transcript
May 7 Agenus (AGEN) Reports Q1 Loss, Misses Revenue Estimates
May 7 Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments
May 7 Agenus Reports First Quarter 2024 Results
May 7 Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
May 1 Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
Apr 28 Up 40%: Is This Red-Hot Growth Stock Still a Buy?
Apr 24 Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
Apr 23 Agenus to Provide First Quarter 2024 Financial Report and Corporate Update